J J Body
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Aapro M, Saad F, Rizzoli R, Paterson A, Monnier A, Lipton A, Jonat W, Hortobagyi G, Hadji P, Gralow J, Gnant M, Dirix L, Crinò L, Costa L, Colomer R, Coleman R, Body J, Abrahamsson P, Thürlimann B. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008; 19:420-32.
01.03.2008Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
01.03.2008Ann Oncol 2008; 19:420-32
Aapro M, Saad F, Rizzoli R, Paterson A H G, Monnier A, Lipton A, Jonat W, Hortobagyi G N, Hadji P, Gralow J, Gnant M, Dirix L, Crinò L, Costa L, Colomer R, Coleman R E, Body J J, Abrahamsson P A, Thürlimann Beat
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
Rizzoli R, Eghbali H, Clemens M, Thürlimann B, Degardin M, Steinhauer E, Tubiana-Hulin M, Manegold C, Rückert F, Huss H, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. The Journal of clinical endocrinology and metabolism 1999; 84:3545-50.
01.10.1999Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
01.10.1999The Journal of clinical endocrinology and metabolism 1999; 84:3545-50
Rizzoli R, Eghbali H, Clemens M R, Thürlimann Beat, Degardin M, Steinhauer E U, Tubiana-Hulin M, Manegold C, Rückert F, Huss H J, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J J
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
Ralston S, Tubiana-Hulin M, Huss H, Hagberg H, Rizzoll R, Lichinitser M, Walls J, Thürlimann B, Steinhauer E, Herrmann Z, Thiébaud D, Body J. Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia. British journal of cancer 1997; 75:295-300.
01.01.1997Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
01.01.1997British journal of cancer 1997; 75:295-300
Ralston S H, Tubiana-Hulin M, Huss H J, Hagberg H, Rizzoll R, Lichinitser M R, Walls J, Thürlimann Beat, Steinhauer E U, Herrmann Z, Thiébaud D, Body J J
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
Pecherstorfer M, Huss H, van Eijkeren M, Steinhauer E, Tubiana-Hulin M, Thürlimann B, Clemens M, Degardin M, Manegold C, Body J, Herrmann Z, Thiébaud D. Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76.
01.01.1996Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
01.01.1996Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76
Pecherstorfer M, Huss H J, van Eijkeren M, Steinhauer E U, Tubiana-Hulin M, Thürlimann Beat, Clemens M R, Degardin M, Manegold C, Body J J, Herrmann Z, Thiébaud D